368 related articles for article (PubMed ID: 35105292)
1. DNA Methylation in Depression and Depressive-Like Phenotype: Biomarker or Target of Pharmacological Intervention?
Paoli C; Misztak P; Mazzini G; Musazzi L
Curr Neuropharmacol; 2022 Nov; 20(12):2267-2291. PubMed ID: 35105292
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation and clinical response to antidepressant medication in major depressive disorder: A review and recommendations.
Lisoway AJ; Zai CC; Tiwari AK; Kennedy JL
Neurosci Lett; 2018 Mar; 669():14-23. PubMed ID: 28063933
[TBL] [Abstract][Full Text] [Related]
3. The Relationship between DNA Methylation and Antidepressant Medications: A Systematic Review.
Webb LM; Phillips KE; Ho MC; Veldic M; Blacker CJ
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012861
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Modifications of Major Depressive Disorder.
Saavedra K; Molina-Márquez AM; Saavedra N; Zambrano T; Salazar LA
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27527165
[TBL] [Abstract][Full Text] [Related]
5. Moving pharmacoepigenetics tools for depression toward clinical use.
Hack LM; Fries GR; Eyre HA; Bousman CA; Singh AB; Quevedo J; John VP; Baune BT; Dunlop BW
J Affect Disord; 2019 Apr; 249():336-346. PubMed ID: 30802699
[TBL] [Abstract][Full Text] [Related]
6. HTR1A/1B DNA methylation may predict escitalopram treatment response in depressed Chinese Han patients.
Wang P; Lv Q; Mao Y; Zhang C; Bao C; Sun H; Chen H; Yi Z; Cai W; Fang Y
J Affect Disord; 2018 Mar; 228():222-228. PubMed ID: 29275155
[TBL] [Abstract][Full Text] [Related]
7. Epigenetics, depression and antidepressant treatment.
Menke A; Klengel T; Binder EB
Curr Pharm Des; 2012; 18(36):5879-89. PubMed ID: 22681167
[TBL] [Abstract][Full Text] [Related]
8. Histone Modifications in Major Depressive Disorder and Related Rodent Models.
Deussing JM; Jakovcevski M
Adv Exp Med Biol; 2017; 978():169-183. PubMed ID: 28523546
[TBL] [Abstract][Full Text] [Related]
9. Epigenetics and depressive disorders: a review of current progress and future directions.
Januar V; Saffery R; Ryan J
Int J Epidemiol; 2015 Aug; 44(4):1364-87. PubMed ID: 25716985
[TBL] [Abstract][Full Text] [Related]
10. Noncoding RNAs in Depression.
Lin R; Turecki G
Adv Exp Med Biol; 2017; 978():197-210. PubMed ID: 28523548
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic mechanisms underlying the role of brain-derived neurotrophic factor in depression and response to antidepressants.
Duclot F; Kabbaj M
J Exp Biol; 2015 Jan; 218(Pt 1):21-31. PubMed ID: 25568448
[TBL] [Abstract][Full Text] [Related]
12. Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response.
Fabbri C; Hosak L; Mössner R; Giegling I; Mandelli L; Bellivier F; Claes S; Collier DA; Corrales A; Delisi LE; Gallo C; Gill M; Kennedy JL; Leboyer M; Lisoway A; Maier W; Marquez M; Massat I; Mors O; Muglia P; Nöthen MM; O'Donovan MC; Ospina-Duque J; Propping P; Shi Y; St Clair D; Thibaut F; Cichon S; Mendlewicz J; Rujescu D; Serretti A
World J Biol Psychiatry; 2017 Feb; 18(1):5-28. PubMed ID: 27603714
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation in interleukin-11 predicts clinical response to antidepressants in GENDEP.
Powell TR; Smith RG; Hackinger S; Schalkwyk LC; Uher R; McGuffin P; Mill J; Tansey KE
Transl Psychiatry; 2013 Sep; 3(9):e300. PubMed ID: 24002086
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylases (HDACs) as therapeutic target for depressive disorders.
Misztak P; Pańczyszyn-Trzewik P; Sowa-Kućma M
Pharmacol Rep; 2018 Apr; 70(2):398-408. PubMed ID: 29456074
[TBL] [Abstract][Full Text] [Related]
15. Serotonin Transporter Gene Promoter Hypomethylation as a Predictor of Antidepressant Treatment Response in Major Depression: A Replication Study.
Schiele MA; Zwanzger P; Schwarte K; Arolt V; Baune BT; Domschke K
Int J Neuropsychopharmacol; 2021 Mar; 24(3):191-199. PubMed ID: 33125470
[TBL] [Abstract][Full Text] [Related]
16. DNA methylations of brain-derived neurotrophic factor exon VI are associated with major depressive disorder and antidepressant-induced remission in females.
Li L; Wang T; Chen S; Yue Y; Xu Z; Yuan Y
J Affect Disord; 2021 Dec; 295():101-107. PubMed ID: 34418778
[TBL] [Abstract][Full Text] [Related]
17. P11 promoter methylation predicts the antidepressant effect of electroconvulsive therapy.
Neyazi A; Theilmann W; Brandt C; Rantamäki T; Matsui N; Rhein M; Kornhuber J; Bajbouj M; Sperling W; Bleich S; Frieling H; Löscher W
Transl Psychiatry; 2018 Jan; 8(1):25. PubMed ID: 29353887
[TBL] [Abstract][Full Text] [Related]
18. Association of the TLR4 gene with depressive symptoms and antidepressant efficacy in major depressive disorder.
Wang J; Yang C; Liu Z; Li X; Liu M; Wang Y; Zhang K; Sun N
Neurosci Lett; 2020 Sep; 736():135292. PubMed ID: 32763359
[TBL] [Abstract][Full Text] [Related]
19. Blood miR-144-3p: a novel diagnostic and therapeutic tool for depression.
van der Zee YY; Eijssen LMT; Mews P; Ramakrishnan A; Alvarez K; Lardner CK; Cates HM; Walker DM; Torres-Berrío A; Browne CJ; Cunningham A; Cathomas F; Kronman H; Parise EM; de Nijs L; Shen L; Murrough JW; Rutten BPF; Nestler EJ; Issler O
Mol Psychiatry; 2022 Nov; 27(11):4536-4549. PubMed ID: 35902629
[TBL] [Abstract][Full Text] [Related]
20. Influence and interaction of genetic, cognitive, neuroendocrine and personalistic markers to antidepressant response in Chinese patients with major depression.
Bi Y; Ren D; Guo Z; Ma G; Xu F; Chen Z; An L; Zhang N; Ji L; Yuan F; Liu L; Hou B; Yang F; Yu S; Yi Z; Xu Y; He L; Sun X; Dong Z; Wu S; Zhao L; Cai C; Li X; Yu T; Shi Y; He G
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110036. PubMed ID: 32702381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
